Navigation Links
Cogdell Spencer Announces a $100 Million Development at St. Luke's Riverside Outpatient Campus In Bethlehem, Pennsylvania
Date:12/27/2007

CHARLOTTE, N.C., Dec. 27 /PRNewswire-FirstCall/ -- Cogdell Spencer Inc. (NYSE: CSA) announces the signing of a new development agreement with St. Luke's Hospital and Health Network of Bethlehem, Pennsylvania to develop the first phase of their Riverside Outpatient Campus. The 383,000 square foot project will consist of a cancer center, an outpatient healthcare pavilion, and two medical office buildings.

The two medical office buildings are valued between $35 and $40 million and will be owned in a single investment entity by Cogdell Spencer and physician investors. The balance of the project will be developed by Cogdell Spencer but owned by St. Luke's. St. Luke's hospital will be the primary tenant of the combined project.

The $100 million project is scheduled for completion during the third quarter of 2009. Ground breaking will begin immediately.

The St. Luke's Riverside Campus first phase new medical facility will be located on 55 acres at Freemansburg Avenue and Route 33, approximately 5 miles from the main St. Luke's hospital campus. The project was previously announced at an onsite ceremony late in the 3rd quarter of 2007.

"Cogdell Spencer and St. Luke's Hospital are pleased to bring the quality of care and patient convenience this state-of-the-art medical office park will offer to Bethlehem Township and the Northampton County area," notes Devereaux Gregg, Vice President of Development for Cogdell Spencer Inc.

This new development with St. Luke's Hospital marks a new client and a new market for Cogdell Spencer. The relationship with St. Luke's Hospital furthers the company's strategic plan of aligning with dominant, non-profit hospital systems with strong local decision making.

"We believe this
'/>"/>

SOURCE Cogdell Spencer Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Cogdell Spencer Inc. Acquires Summit Professional Plaza I and II in Brunswick, Georgia
2. Cogdell Spencer Inc. Reports Third Quarter 2007 Financial Results
3. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
4. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
5. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
6. HEI, Inc. Announces Sale of RFID Division Assets
7. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
8. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
9. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
10. Brooke Franchise Corporation Announces Selected July Results
11. Manor Care, Inc. Announces Record Date for Special Stockholder Meeting

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...RAMENTO, Calif., Nov. 9 Sutter Hea... and other health care service providers, is donat...nia. A variety of local food banks will share the ...eeded meals on the tables of thousands of families... a long history of partnering with and supporting ...
(Date:11/9/2009)...use action backs President Obama,s promise to not ...xample ,, Bishops still concerned for poor, e...swire/ -- Cardinal Francis George of Chicago, pres...Bishops, lauded the November 7 decision of the U.S... care reform money from paying for elective aborti...
(Date:11/9/2009)...y be left atrial enlargement, study finds , ...s a major risk factor for left atrial enlargement,...stroke and death, a new study shows. , Atrial f...(an irregular heart rhythm or heartbeat). , Re...ed 25 to 74, in Germany who were followed for 10 y...
(Date:11/9/2009)... Networking is everybody,s buzz wo...Money. StaffingClub.com enables Recruiters and Sta... to connect, share, communicate and close position... post their profiles and network with recruiters. ...9 -- Current Job Market forces everyone to network...
(Date:11/9/2009)...n of plans finds differences in mood despite simil...hDay News) -- Both a high-fat, low-carbohydrate di...t, high-carb diet appear to help people lose pound...? Only the low-fat diets will result in long-term ...ov. 9 issue of Archives of Internal Medicine . ,...
Breaking Medicine News(10 mins):Health News:Sutter Health Donates $255,000 to Help the Hungry This Holiday Season 2Health News:Cardinal George Lauds House Action to Ban Federal Funds for Abortion; Promises Vigilance as Senate Pursues Health Care Reform, Wary About Affect on Poor, Elderly 2Health News:Cardinal George Lauds House Action to Ban Federal Funds for Abortion; Promises Vigilance as Senate Pursues Health Care Reform, Wary About Affect on Poor, Elderly 3Health News:Launching StaffingClub.com, a New Online Networking Platform for Recruiting and Staffing Professionals 2Health News:To Feel Better, Low-Fat Diet May Be Best 2Health News:To Feel Better, Low-Fat Diet May Be Best 3
...ogical protein, especially present in the central ...h functions that are little known as yet. Altered ...ns, are responsible for spongiform encephalopathie...the importance of this investigation for the locat...
...wood stars like Kamal Hassan, Chiranjeevi, Nagarj...evathi gathers for a show in Hyderabad to spread t...For Heroes,' was sponsored by agencies including t...y proud of my acting community for coming forward....
...at depression may not be the only factor-probing a...ers might therefore need to watch out for other me... The World Health Organization re-examined the occ...revealed a majority of them were due to mood disor...
...on cardiac output, oxygen consumption, and myocard...er, the influence of heart rate on myocardial oxyg...uction of flexible pO2 micro catheters to measure ...udy, researchers from Germany examined the effect ...
... the journey from London to India in order to save... India is likely to attract more such patients ...gical procedures and medication.Fifty-year-old Lin... Herceptin is an expensive anti-cancer drug Linda...
...disorder of impaired insulin secretion and insulin...he identification of high-risk individuals and lif...er, most patients require pharmacologic interventi...ize the risk of future micro- and macrovascular co...
Other Medicine News:Health News:The 'Mad Cow' Disease And Protein 2Health News:Multi targeted approach required for suicide prevention in adolescents 2Health News:Influence Of Heart Rate On Myocardial Oxygen Tension 2Health News:Glimepiride in the medical management of Type 2 diabetes 2
(Date:11/9/2009)...ov. 9 ISTA Pharmaceutica...nal results from the Company,s Bepreve(TM) (bepota...linical studies. These results were presented in ...American College of Allergy, Asthma & Immunolo...presentation titled, "Treatment of Ocular Itching ...
(Date:11/9/2009)... Mass., Nov. 9 Decision Resources,...firms for pharmaceutical and healthcare issues, fi...eceptor 2 (HER2) targeting therapies -- which incl...ippon Kayaku,s Tykerb/Tyverb -- were the highest-s...inued uptake of Herceptin and Tykerb/Tyverb and th...
(Date:11/9/2009)...PHIA, Nov. 9 Shire plc...ty biopharmaceutical company, today announced the ...ded Release Tablets in pharmacies across the Unite...peractivity Disorder ( ADHD ) in children and ad...mulation of guanfacine, is the first and only nons...
Breaking Medicine Technology:ISTA Pharmaceuticals Highlights Bepreve(TM) Clinical Data at the 2009 Annual Meeting of the American College of Allergy, Asthma & Immunology (ACAAI) 2ISTA Pharmaceuticals Highlights Bepreve(TM) Clinical Data at the 2009 Annual Meeting of the American College of Allergy, Asthma & Immunology (ACAAI) 3Sales of HER2-Targeting Agents for Breast Cancer, Including Herceptin and Tykerb/Tyverb, Will Grow by 3.3 Percent Annually from 2008 to 2018 2Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets Now Available in Pharmacies Nationwide 2Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets Now Available in Pharmacies Nationwide 3Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets Now Available in Pharmacies Nationwide 4Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets Now Available in Pharmacies Nationwide 5Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets Now Available in Pharmacies Nationwide 6Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets Now Available in Pharmacies Nationwide 7BCBSF to Cover the Administration of H1N1 Vaccination for All Members 57166 1BCBSF to Cover the Administration of H1N1 Vaccination for All Members 57166 2Research Councils UK sign groundbreaking MoU with Brazil 9928 1Research Councils UK sign groundbreaking MoU with Brazil 9928 2Research Councils UK sign groundbreaking MoU with Brazil 9928 3BioCryst Announces Partnerships for Peramivir for Influenza Outside the U S 57160 1BioCryst Announces Partnerships for Peramivir for Influenza Outside the U S 57160 2BioCryst Announces Partnerships for Peramivir for Influenza Outside the U S 57160 3BioCryst Announces Partnerships for Peramivir for Influenza Outside the U S 57160 4BioCryst Announces Partnerships for Peramivir for Influenza Outside the U S 57160 5
...y 15 Cytopia Limited,(ASX: CYT) today announced t...n on CYT997 at the 2008 Annual Meeting of the Amer...ccessible to the public via ASCO,s,website (http:...DT)., The oral presentation, entitled "Phase I ev... disrupting agent, in patients with advanced cance...
... Schering-Plough,Corporation (NYSE: SGP ), a lea...nic hepatitis C virus (HCV) infection, announced t...PEGINTRON(TM) (peginterferon alfa-2b) and,REBETOL(...s boceprevir, the,company,s investigational oral H...th annual Digestive Disease Week (DDW) meeting to ...
Other Medicine Technology:Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 2Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 3Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 4Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 5Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 6Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 7
FemoStop
VasoSeal VHD KIT 6
VasoSeal VHD KIT 4
Hemapatch Knitted
Medicine Products: